top of page

Alvaro Lladser

Principal Investigator

Immunoncology Lab

Dr. Lladser is a Biochemist with a PhD in Biomedical Sciences from Universidad de Chile, and did his postdoctoral training at the Cancer Center of the Karolinska Institute, Stockholm, Sweden.

Since the end of 2010, Dr. Lladser directs the Laboratory of Immunoncology at Fundación Ciencia & Vida and since 2019 he is Associate Professor at the Faculty of Medicine and Science of Universidad San Sebastián. He is currently Principal Investigator of the Centro Basal Ciencia & Vida (FB210008), of a FONDECYT Regular grant (1212070), and coinvestigator in several collaborative projects.

His research focuses on unraveling the complex molecular and cellular networks that underlie effective T cell-mediated antitumor immunity by analyzing human samples using high-dimensional transcriptomics and phenotypic analyses, as well as ex vivo functional assays and in vivo tumor models.

Grants

2031-2021Principal Investigator Centro Basal Centro Ciencia & Vida, FB210008. ANID, Chile. 2030-2025Principal Investigator FONDECYT Regular Grant 1251312. ANID, Chile. Unveiling the helper role of Treg cells in long-lasting CD8 T cell immunity induced by cancer immunotherapy. Since 2025 Principal Investigator, Collaboration Fundación Ciencia & Vida - Fundación López Pérez. 2025-2024 Principal Investigator PCI-FOVI240247: Red de Colaboración en Inmunología e Inmunoterapia entre Francia, Argentina y Chile. 2025-2022Co-Investigator FONDEF IDeA Grant ID22I1007. PI: Dr. Rodrigo Pacheco. ANID, Chile. Evaluación de la eficacia y seguridad de una inmunoterapia supresora específica para alfa-sinucleina nitrada como tratamiento para la enfermedad de Parkinson en un modelo preclínico. 2026-2022Co-Investigator FONDECYT Regular Grant 1220196. PI: Dr. Daniela Sauma, ANID, Chile. Not too much, not too little, just right: the unexpected role of adenosine in the antitumor immune response. 2025-2021Principal Investigator FONDECYT Regular Grant 1212070. ANID, Chile. Unveiling the crosstalk between CD8 T cells and dendritic cells underlying effective and long-lasting antitumor immunity.

Collaborations

Dr. Maria Rosa Bono, Dr. Daniela Sauma. Dr. Fabiola Osorno, Dr. Flavio Salazar | Universidad de Chile Dr. Eliane Piaggio, Dr. Ana María Lennon | Institut Curie Dr. Felipe Galvez-Cancino | University of Oxford Dr. Sergio Quezada | University College London Dr. Eduardo Villablanca | Karolinska Institutet Dr. Manuel Varas Godoy, Dr. Rodrigo Pacheco, Dr. Alejandra Loyola, Dr. Hugo González, Dr. Alberto Martín | Universidad San Sebastián

Selected Publications

Oncoimmunology

DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models

Morgado-Cáceres P, Hofmann-Vega F, Figueroa D, Saavedra-Almarza J, Gálvez-Cancino F, Díaz X, Menares E, Roa E, Hidalgo S, Varas-Godoy M, Borgna V, Lladser A

DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models

Morgado-Cáceres P, Hofmann-Vega F, Figueroa D, Saavedra-Almarza J, Gálvez-Cancino F, Díaz X, Menares E, Roa E, Hidalgo S, Varas-Godoy M, Borgna V, Lladser A

Bioinformatics Advances

scExplorer: a comprehensive web server for single-cell RNA sequencing data analysis

Hernández-Galaz S, Hernández-Olivera A, Villanelo F, Lladser A, Martin AJM

scExplorer: a comprehensive web server for single-cell RNA sequencing data analysis

Hernández-Galaz S, Hernández-Olivera A, Villanelo F, Lladser A, Martin AJM

Cell

Exploring Latin America one cell at a time

Possik PA, Adams DJ, Aguiar FC, Alves TC, Alves-Hanna FS, Restrepo Arboleda CM, Armingol E, Arruda LB, Astroz YC, Boccacino JM, Bonfim DC, Calderon JF, Murillo Carrasco AG, Carvalho DG, Carvalho BS, Sanches Daltro de Carvalho PV, Castro A, Chappell L, Chinchilla-Monge R, Di Bella D, Gomes Dias SM, Fagundes R, Fernández ML, Frade BB, Garde FJ, Gonzalez H, Guimarães GR, Inchausti L, Kordon E, Leaden L, Lima RS, Lladser A, López-Castiblanco J, Malta I, Maracaja-Coutinho V, Marchese D, Matimba A, Moreno-Estrada A, Mori MA, Nakaya H, Pereyra S, Romo Ramos YJ, Rego N, Robles-Espinoza CD, Rojas-Hidalgo A, Rubinsztain MN, Santos L, Scoones A, Severino P, Sousa-Squiavinato ACM, Spangenberg L, Suescún AV, Tessarollo NG, Vázquez-Cruz ME, Zawati MH, Viola JPB, Boroni M

Possik PA, Adams DJ, Aguiar FC, Alves TC, Alves-Hanna FS, Restrepo Arboleda CM, Armingol E, Arruda LB, Astroz YC, Boccacino JM, Bonfim DC, Calderon JF, Murillo Carrasco AG, Carvalho DG, Carvalho BS, Sanches Daltro de Carvalho PV, Castro A, Chappell L, Chinchilla-Monge R, Di Bella D, Gomes Dias SM, Fagundes R, Fernández ML, Frade BB, Garde FJ, Gonzalez H, Guimarães GR, Inchausti L, Kordon E, Leaden L, Lima RS, Lladser A, López-Castiblanco J, Malta I, Maracaja-Coutinho V, Marchese D, Matimba A, Moreno-Estrada A, Mori MA, Nakaya H, Pereyra S, Romo Ramos YJ, Rego N, Robles-Espinoza CD, Rojas-Hidalgo A, Rubinsztain MN, Santos L, Scoones A, Severino P, Sousa-Squiavinato ACM, Spangenberg L, Suescún AV, Tessarollo NG, Vázquez-Cruz ME, Zawati MH, Viola JPB, Boroni M

Immunity

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies

Felipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, Simone Puccio, Enrique Conde-Gallastegi, Kane Foster, Yasmin Morris, Teerapon Sahwangarrom, Despoina Karagianni, Jiali Liu, Alvin J X Lee, Dimitrios A Garyfallos, Alexander P Simpson, Gerasimos-Theodoros Mastrokalos, Francesco Nannini, Cristobal Costoya, Varshaa Anantharam, Beatrice Claudia Cianciotti, Leanne Bradley, Claudia Garcia-Diaz, Melanie Clements, Aditya Shroff, Fatemeh Vahid Dastjerdi, Enrique Miranda Rota, Shahida Sheraz, Robert Bentham, Imran Uddin, Henning Walczak, Alvaro Lladser, James L Reading, Kerry A Chester, Martin A Pule, Paul M Brennan, Samuel Marguerat, Simona Parrinello, Karl S Peggs, Nicholas McGranahan, Enrico Lugli, Kevin Litchfield, Steven M Pollard, Sergio A Quezada

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies

Felipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, Simone Puccio, Enrique Conde-Gallastegi, Kane Foster, Yasmin Morris, Teerapon Sahwangarrom, Despoina Karagianni, Jiali Liu, Alvin J X Lee, Dimitrios A Garyfallos, Alexander P Simpson, Gerasimos-Theodoros Mastrokalos, Francesco Nannini, Cristobal Costoya, Varshaa Anantharam, Beatrice Claudia Cianciotti, Leanne Bradley, Claudia Garcia-Diaz, Melanie Clements, Aditya Shroff, Fatemeh Vahid Dastjerdi, Enrique Miranda Rota, Shahida Sheraz, Robert Bentham, Imran Uddin, Henning Walczak, Alvaro Lladser, James L Reading, Kerry A Chester, Martin A Pule, Paul M Brennan, Samuel Marguerat, Simona Parrinello, Karl S Peggs, Nicholas McGranahan, Enrico Lugli, Kevin Litchfield, Steven M Pollard, Sergio A Quezada

Selected Publications

Oncoimmunology

DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models

Morgado-Cáceres P, Hofmann-Vega F, Figueroa D, Saavedra-Almarza J, Gálvez-Cancino F, Díaz X, Menares E, Roa E, Hidalgo S, Varas-Godoy M, Borgna V, Lladser A

Bioinformatics Advances

scExplorer: a comprehensive web server for single-cell RNA sequencing data analysis
scExplorer: a comprehensive web server for single-cell RNA sequencing data analysis

Hernández-Galaz S, Hernández-Olivera A, Villanelo F, Lladser A, Martin AJM

Cell

Exploring Latin America one cell at a time

Possik PA, Adams DJ, Aguiar FC, Alves TC, Alves-Hanna FS, Restrepo Arboleda CM, Armingol E, Arruda LB, Astroz YC, Boccacino JM, Bonfim DC, Calderon JF, Murillo Carrasco AG, Carvalho DG, Carvalho BS, Sanches Daltro de Carvalho PV, Castro A, Chappell L, Chinchilla-Monge R, Di Bella D, Gomes Dias SM, Fagundes R, Fernández ML, Frade BB, Garde FJ, Gonzalez H, Guimarães GR, Inchausti L, Kordon E, Leaden L, Lima RS, Lladser A, López-Castiblanco J, Malta I, Maracaja-Coutinho V, Marchese D, Matimba A, Moreno-Estrada A, Mori MA, Nakaya H, Pereyra S, Romo Ramos YJ, Rego N, Robles-Espinoza CD, Rojas-Hidalgo A, Rubinsztain MN, Santos L, Scoones A, Severino P, Sousa-Squiavinato ACM, Spangenberg L, Suescún AV, Tessarollo NG, Vázquez-Cruz ME, Zawati MH, Viola JPB, Boroni M

Immunity

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies

Felipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, Simone Puccio, Enrique Conde-Gallastegi, Kane Foster, Yasmin Morris, Teerapon Sahwangarrom, Despoina Karagianni, Jiali Liu, Alvin J X Lee, Dimitrios A Garyfallos, Alexander P Simpson, Gerasimos-Theodoros Mastrokalos, Francesco Nannini, Cristobal Costoya, Varshaa Anantharam, Beatrice Claudia Cianciotti, Leanne Bradley, Claudia Garcia-Diaz, Melanie Clements, Aditya Shroff, Fatemeh Vahid Dastjerdi, Enrique Miranda Rota, Shahida Sheraz, Robert Bentham, Imran Uddin, Henning Walczak, Alvaro Lladser, James L Reading, Kerry A Chester, Martin A Pule, Paul M Brennan, Samuel Marguerat, Simona Parrinello, Karl S Peggs, Nicholas McGranahan, Enrico Lugli, Kevin Litchfield, Steven M Pollard, Sergio A Quezada

bottom of page